Suppr超能文献

急性心肌梗死后使用美托洛尔缓释片改善运动能力和左心室舒张功能。

Improvement of exercise capacity and left ventricular diastolic function with metoprolol XL after acute myocardial infarction.

作者信息

Poulsen S H, Jensen S E, Egstrup K

机构信息

Section of Cardiology, Department of Medicine, Haderslev Hospital, Denmark.

出版信息

Am Heart J. 2000 Jul;140(1):E6-11. doi: 10.1067/mhj.2000.106914.

Abstract

BACKGROUND

Left ventricular (LV) diastolic function predicts and correlates with exercise capacity. Beta-blockers improve exercise capacity and LV diastolic function in patients with severe LV systolic dysfunction in dilated cardiomyopathy. However, information on the effect of metoprolol XL on exercise capacity in relation to LV diastolic function in patients with mild to moderate LV systolic dysfunction after acute myocardial infarction is limited.

METHODS

In a randomized, double-blind, placebo-controlled study of 77 patients, a subgroup of 59 patients with mild to moderate LV systolic dysfunction after acute myocardial infarction were given metoprolol XL (n = 29) or placebo (n = 30). The effects of metoprolol XL on exercise capacity in relation to effects on LV diastolic filling were studied. Two-dimensional Doppler echocardiography and maximal symptom limited bicycle test were performed on days 5 through 7 and after 3 months.

RESULTS

Maximal exercise capacity increased in the metoprolol XL group (124 +/- 30 W vs 135 +/- 29 W) compared with placebo (125 +/- 31 W vs 126 +/- 34 W) (P <.01). E/A ratio decreased, A peak velocity increased, reverse pulmonary flow decreased, and deceleration time was significantly prolonged in the metoprolol XL group. A significant correlation was found between the changes of deceleration time (metoprolol XL: rho = 0.69, P <.0001; placebo: rho = 0.31, P = not significant) and A peak velocity (metoprolol XL: rho = 0.71, P <.0001; placebo: rho = -0.15, not significant) in relation to changes of exercise capacity.

CONCLUSION

Metoprolol XL increases exercise capacity after 3 months, and this change seems related to improvement of LV diastolic filling after acute myocardial infarction.

摘要

背景

左心室舒张功能可预测运动能力并与之相关。β受体阻滞剂可改善扩张型心肌病严重左心室收缩功能不全患者的运动能力和左心室舒张功能。然而,关于美托洛尔缓释片对急性心肌梗死后轻至中度左心室收缩功能不全患者运动能力及左心室舒张功能影响的信息有限。

方法

在一项对77例患者进行的随机、双盲、安慰剂对照研究中,59例急性心肌梗死后轻至中度左心室收缩功能不全患者的亚组被给予美托洛尔缓释片(n = 29)或安慰剂(n = 30)。研究了美托洛尔缓释片对运动能力的影响及其与左心室舒张充盈的关系。在第5至7天以及3个月后进行二维多普勒超声心动图检查和症状限制最大运动自行车试验。

结果

与安慰剂组相比,美托洛尔缓释片组的最大运动能力增加(124±30W对135±29W)(安慰剂组为125±31W对126±34W)(P<.01)。美托洛尔缓释片组的E/A比值降低、A峰速度增加、肺静脉反流减少且减速时间显著延长。发现减速时间变化(美托洛尔缓释片组:rho = 0.69,P<.0001;安慰剂组:rho = 0.31,P无统计学意义)和A峰速度变化(美托洛尔缓释片组:rho = 0.71,P<.0001;安慰剂组:rho = -0.15,无统计学意义)与运动能力变化之间存在显著相关性。

结论

美托洛尔缓释片在3个月后可提高运动能力,且这种变化似乎与急性心肌梗死后左心室舒张充盈的改善有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验